SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001387131-22-007848
Filing Date
2022-07-21
Accepted
2022-07-21 16:23:26
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS admp-defa14a_072022.htm DEFA14A 55477
2 GRAPHIC saratogalogo.jpg GRAPHIC 5728
3 GRAPHIC letter_001.jpg GRAPHIC 2756
  Complete submission text file 0001387131-22-007848.txt   68550
Mailing Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36242 | Film No.: 221097324
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences